Tuesday, March 17, 2026

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

South Korea Emerges as Key Ally in U.S. Navy’s $1 Trillion Fleet Expansion

The U.S. plans to invest $1 trillion over 30 years to expand its naval fleet, emphasizing the need for alliances like South Korea.

North Korea Unveils Nuclear-Powered Submarine: “Strategic Stage Entry” VS “Combat Readiness Is Not Yet”

North Korea reveals its 8,700-ton nuclear-powered submarine, indicating advancements in its strategic missile capabilities.

Tag: Multiple Myeloma

J&J Aims to Treat Cancer Before It Starts Showing Symptoms

Johnson & Johnson leads in multiple myeloma treatment, pioneering early intervention for high-risk patients with a new subcutaneous formulation.

Top News

- Our Sponsors Ad -

Follow us